- Home
- COLL vs JKS Comparison
COLL vs JKS Comparison
Compare COLL & JKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COLL | JKS |
|---|---|---|
| Founded | 2002 | 2006 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.2B |
| IPO Year | 2015 | 2010 |
Fundamental Metrics
Financial Performance| Metric | COLL | JKS |
|---|---|---|
| Price | $47.02 | $25.50 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 5 |
| Target Price | ★ $47.50 | $28.59 |
| AVG Volume (30 Days) | 550.1K | ★ 713.3K |
| Earning Date | 11-06-2025 | 11-17-2025 |
| Dividend Yield | N/A | ★ 5.88% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.63 | N/A |
| Revenue | $757,067,000.00 | ★ $9,641,756,390.00 |
| Revenue This Year | $26.35 | N/A |
| Revenue Next Year | $3.67 | $31.11 |
| P/E Ratio | $29.21 | ★ N/A |
| Revenue Growth | ★ 26.34 | N/A |
| 52 Week Low | $23.23 | $13.42 |
| 52 Week High | $49.09 | $31.88 |
Technical Indicators
Market Signals| Indicator | COLL | JKS |
|---|---|---|
| Relative Strength Index (RSI) | 68.88 | 48.68 |
| Support Level | $46.81 | $24.01 |
| Resistance Level | $49.09 | $26.48 |
| Average True Range (ATR) | 1.33 | 1.20 |
| MACD | -0.19 | -0.26 |
| Stochastic Oscillator | 69.59 | 27.57 |
Price Performance
Historical ComparisonAbout COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About JKS JinkoSolar Holding Company Limited (each representing 4)
JinkoSolar Holding Co Ltd is engaged in the photovoltaic industry. The firm has built a vertically integrated solar power product value chain, manufacturing from silicon wafers to solar modules. It sells solar modules under the JinkoSolar brand. The company's products include Silicon wafers, Solar cells, and Solar modules. Its geographical segments are China (including Hong Kong and Taiwan), North America, Europe, Asia Pacific, and the Rest of the world.